TELA Bio (TELA) Revenue (2018 - 2026)

TELA Bio has reported Revenue for 9 years, with the latest figure at $19.1 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 2.91% year-over-year to $19.1 million; the trailing twelve-month figure through Mar 2026 stood at $80.8 million (up 13.48% YoY), and the FY2025 full-year result was $80.3 million, up 15.84% from the prior year.
• Revenue for Q1 2026 stood at $19.1 million, down from $20.9 million in the prior quarter.
• The five-year high for Revenue was $20.9 million in Q4 2025, with the low at $8.2 million in Q1 2022.
• Average Revenue over 5 years is $15.8 million, with a median of $16.6 million recorded in 2024.
• Year-over-year, Revenue jumped 46.26% in 2023 and grew 2.91% in 2026.
• Tracing TELA's Revenue over 5 years: stood at $11.6 million in 2022, then surged by 46.26% to $17.0 million in 2023, then advanced by 3.83% to $17.6 million in 2024, then gained by 18.24% to $20.9 million in 2025, then dropped by 8.67% to $19.1 million in 2026.
• The last three Revenue figures came in at $19.1 million (Q1 2026), $20.9 million (Q4 2025), and $20.7 million (Q3 2025), per Business Quant data.

Peer Comparison